急诊内科老年重症心力衰竭的临床治疗分析

目的：分析急诊内科老年重症心力衰竭的临床治疗方案及疗效。方法：回顾性分析我院2010-03～2012—10收治的86例老年重症心力衰竭患者，随机分为观察组、对照组各43例。对照组行常规心力衰竭对症治疗，观察组在上述常规治疗的基础上行美托洛尔联合厄贝沙坦氢氯噻嗪治疗。分别对2组的治疗效果进行评价，同时对患者LVEF、BNP、NYHA三项指标进行观察统计。结果：观察组总有效率为90．7％，对照组为79．07％，2组差异具有显著性（P〈0．01）。治疗后，两组的LVEF、BNP、NYHA指标较治疗前均改善（P〈0．05），但观察组的改善程度要大于对照组（P〈0．05）。结论：急诊内科老年重症心力衰竭的临床治疗中，在常规心力衰竭对症治疗的基础上行美托洛尔联合厄贝沙坦氢氯噻嗪临床效果显著。

Emergency medical treatment of severe heart failure in elderly patients

Objective.To analyze the clinical treatment and curative effect of severe heart failure in elderly patients in the emergency medicine. Methods. From January 2011 to December 2012, 86 elderly patients with severe heart failure were randomly divided into 2 groups, observation group （n=43） and control group （n=43）. The patients incontrol group were treated with conventional symptomatic treatment, and the patients in observation group were treated with metoprolol and irbesartan hydrochlorothiazide combind with conventional treatment. The treatment outcomes were evaluated and the LVEF, BNP and NYHA were observed. Results. The total effective rates in observation and control group were 90. 7% and 79.07X respectively （P〈0.01）. The LVEF, BNP and NYHA after treatment were improved than those before treatment （P〈0.05）. But the improvement levels in observation group were higher than those in control group （P〈0. 05）. Conclusion： For the elderly patients with severe heart failure receiving the conventional treatment in emergency medicine, the metoprolol combined with irbesartan hydrochlorothiaz- ide could obviously improve the therapeutic efficacy.